Please login to the form below

Not currently logged in

Marschall Runge joins Lilly’s board of directors

Will serve on the pharma company's Science and Technology, and Public Policy and Compliance Committees

Lilly Marschall Runge Lilly has added academic experience to its board of directors with the appointment of Dr Marschall Runge, who is executive dean for the School of Medicine at the University of North Carolina (UNC).

Dr Runge will serve on Lilly's Science and Technology Committee and the Public Policy and Compliance Committee, where he will use his years of experience in medicines research and healthcare to provide advice on company strategies.

This experience includes his current role at UNC, where he provides overall academic and clinical leadership for the School of Medicine.

Dr Runge also currently serves as principal investigator and director of the North Carolina Translational and Clinical Sciences (NC TraCS), one of 60 medical research institutions that form a national consortium to improve the way biomedical research is conducted across the US.

His previous positions include faculty member at Harvard's Massachusetts General Hospital and associate professor of medicine at Emory University.

“Dr Runge brings to the Lilly board a broad background in healthcare, with extensive experience as a practicing physician, clinical researcher, and dean of a major academic medical institution,” said Dr John Lechleiter, Lilly's chairman, president and CEO.

“His appreciation of the importance of scientific research, coupled with his first-hand experience in patient care, will help Lilly deliver on its commitment to discover and develop innovative medicines that make a difference for patients in need."

30th August 2013

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...